Similar articles

• [Clexane in prevention of acute venous thrombosis and pulmonary thromboembolism].

  Kirienko AI, Zolotukhin IA. Kirienko AI, et al. Ter Arkh. 1998;70(11):78-80. Ter Arkh. 1998. PMID: 9949471 Review. Russian. No abstract available.
• A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.

  Lynd LD, Goeree R, Crowther MA, O'Brien BJ. Lynd LD, et al. Can J Clin Pharmacol. 2007 Summer;14(2):e215-26. Epub 2007 Jun 6. Can J Clin Pharmacol. 2007. PMID: 17652767
• The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.

  Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, O'Riordan W, Pineo GF; PREVAIL Investigators. Sherman DG, et al. Lancet. 2007 Apr 21;369(9570):1347-1355. doi: 10.1016/S0140-6736(07)60633-3. Lancet. 2007. PMID: 17448820 Clinical Trial.
• Venous thrombosis after acute spinal cord injury: cost analysis of prophylaxis guidelines.

  Wade WE, Chisholm MA. Wade WE, et al. Am J Phys Med Rehabil. 2000 Nov-Dec;79(6):504-8. doi: 10.1097/00002060-200011000-00003. Am J Phys Med Rehabil. 2000. PMID: 11083299 Review.
• Prevention of venous thromboembolism after acute ischaemic stroke.

  Melero MJ, Bergroth B, Contardo DM, Mazzei MM. Melero MJ, et al. Lancet. 2007 Sep 1;370(9589):735; author reply 736-7. doi: 10.1016/S0140-6736(07)61364-6. Lancet. 2007. PMID: 17765510 No abstract available.